Company: PTHS
Filing Date: 2025-03-27
Form Type: 10-K
Source: 0001753926-25-000503
Chunk: 2039

Company: Pelthos Therapeutics Inc.
Filing Date: 2025-03-27
Form: 10-K
Item: Item 10
Chunk 2039
---
 implemented a formal policy with respect to compensation payable to our non-employee directors. From time to time, we
have granted equity awards to attract individuals to join our board of directors and for their continued service thereon. In 2024,
independent directors received $14,396 in cash compensation. In addition, in 2024 directors were granted options to purchase 90,000
shares of Common Stock at fair market value as of the date of issuance, expiring ten years from issuance and RSUs representing
356,664 shares of Common Stock. In addition, we reimburse our directors for expenses associated with attending meetings of our
board of directors and its committees. Our board of directors is still in the process of considering the non-employee director
compensation policy.

    Name 
    Fees Earned  or Paid in  Cash ($)  
    Stock  Awards ($)  
    Stock  Option  Awards ($)(1)  
    Non-Equity  Incentive  Plan  Compensation ($)  
    Nonqualified  Deferred  Compensation  Earnings ($)  
    All Other  Compensation ($)  
    Total ($) 

    Todd Davis 
     14,396  
     52,258  
     299,215  
     —  
     20,000  
     —  
     385,869 

    Ezra Friedberg 
     14,396  
     26,111  
     149,608  
     —  
     20,000  
     —  
     210,115 

    Richard Malamut 
     14,396  
     26,111  
     149,608  
     —  
     20,000  
     —  
     210,115 

    Chia-Lin Simmons 
     14,396  
        
     183,675  
     —  
     20,000  
     —  
     218,071 

(1)
Amounts reflect the aggregate grant date fair value of the stock options granted to each named executive officer during the fiscal
year ended December 31, 2024 and 2023, as computed in accordance with Financial Accounting Standards Board ASC 718.

95 

Policies
and Practices Related to The Grant of Certain Equity Awards

We
maintain the 2023 Plan